The morning of September 17, Belgium UCB Pharma (UCB) Vice President Philip a. Goliber visit Institute of Biophysics, Chinese Academy of Sciences.
Xu Ruiming introduces the main research areas of the Institute's progress in scientific research, international cooperation and exchanges Department Institute introduces the overall situation. Goliber Dr UCB Pharma's profile and the purpose of the visit. Both sides on possible areas of future cooperation and forms of cooperation were discussedAfter the meeting, Dr Goliber visited of the protein science platform, heard a platform of equipment and research briefings. Goliber excellent scientific research of the Institute Dr device efficiency and left a deep impression.
Belgium UCB Pharma (UCB) was founded in 1928 and headquartered in Belgium Brussels, London, Slough and Cambridge has 3 research and Development Center. UCB Pharma is committed to to the patient (the central nervous system and the immune system) to provide more innovative treatments, with operations in more than 40 countries, employs 8,500 staff. 2010 global sales revenue of 3.6 billion euros, is Belgium's largest pharmaceutical companies, pharmaceutical industry ranks 27th in the world.